Trial Site Detail
Drug: |
Sutent (Sunitinib, SU11248)
+ Sirolimus (Rapamycin, Rapamune) |
|||
|---|---|---|---|---|
Trial: |
A Study of the Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors That Are Non-Curable With Standard Therapy |
|||
| Conditions: | Solid Tumors | |||
Trial Status: |
Ongoing, but not recruiting |
|||
Yale University School of Medicine333 Cedar St |
Principal Investigator: |
|
|---|---|
Contact: |
|
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Yale University School of Medicine Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.